A drug called evolocumab, when given every two weeks, cuts bad cholesterol by more than 60% in people at high risk for heart problems — and that result has shown up consistently in several major studies.

A drug called alirocumab, given as a 75mg shot every couple of weeks, lowered bad cholesterol by almost half in people at high risk for heart problems over six months — a bit less than another similar drug, evolocumab.

For people with diabetes who don’t have serious artery disease, adding a drug called evolocumab to their usual cholesterol medicine lowers bad cholesterol a lot — down to 52, compared to 111 without it — after a year.

For people with diabetes or clogged arteries who haven’t had a heart attack or stroke yet, taking a drug called evolocumab every two weeks can lower their chance of having a first heart attack, stroke, or heart-related death by about 25% over nearly 5 years.

Even if your cholesterol is already pretty low thanks to statins, adding a drug called evolocumab can still help protect your heart and blood vessels.

For people with heart disease who are already taking cholesterol-lowering pills, adding a drug called evolocumab can slash their bad cholesterol by about 60% in less than a year—bringing it down to very low levels.